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I. Introduction 
The red cells of patients with inherited eficiencies 
of glucose-6-phosphate dehydrogenase (G-6-PD) are 
sensitive to the haemolytic effects of a wide variety 
of drugs such as phenylhydrazine, primaquine, acetyl- 
salicylic acid and favabean [I]. The oxidative damage 
induced by such haemolytic agents may be caused by 
the generation of hydrogen peroxide, superoxide and 
hydroxyl radicals from the autoxidation of the active 
drug or its metabolites, orvia a linked oxidation 
between oxyhaemoglobin a d the drug or its metab- 
elites [2-4]. These reactive species have the capacity 
to initiate the peroxidation of unsaturated fatty acids 
in the erythrocyte membrane phospholipids [5,6]. 
Oxidation of reduced glutathione is the major path- 
way of hydrogen peroxide metabolism in intact eryth- 
rocytes [7]. Continuous reduction of the oxidised 
glutathione is dependent on glutathione r ductase, 
which itself is (NADPH + H)-dependent. The reduced 
form of this coenzyme is in short supply in individuals 
deficient in glucose-6-phosphate dehydrogenase and 
the resulting failure to maintain ormal concentra- 
tions of reduced glutathione and the accompanying 
intracellular ccumulation fhydrogen peroxide and 
oxidising radicals leads to the oxidation of free sul- 
phydryl groups. 
The red cell membranes from G-6-PD-deficient 
individuals with accompanying chronic haemolytic 
disease may contain polypeptide aggregates involving 
spectrin, dissociable by disulphide reducing agents 
[8,9]. These aggregates are considered tobe indicators 
of oxidant damage to the red cell membrane l ading 
to decreased deformability and haemolysis. 
This work involves the erythrocytes from patients 
with the less severe and more common G-6-PD mutant 
of the A- and Mediterranean-types which are charac- 
terised clinically by intermittent haemolysis a sociated 
with drug treatment or infection; their catalytic activ- 
ity is ~20-40% of the average activity of normal 
fresh human red cells. The results indicate the fol- 
lowing membrane changes in such erythrocytes: 
(i) The bulk lipid fluidity is increased; 
(ii) The cholesterol:phospholipid ratio is decreased; 
(lii) The lipid peroxidation level is elevated. 
2. Materials and methods 
Fresh human erythrocytes were taken from 
haematologically normal donors and from patients 
with G-6-PD deficiency (Mediterranean- and A- types). 
Samples were removed for the assay of glucose-6- 
phosphate dchydrogenase and ATP levels using the 
UV-method test-combination kits from Boehringer. 
Further samples were collected for the extraction of 
total ipid [10] and for phospholipid and cholesterol 
analysis [11 ]. 
Erythrocyte membranes were prepared within 24 h 
essentially applying the method in [12] but using 
Tris buffers and ghosts were finally suspended in Tris- 
HC1 buffer in isotonic saline (pH 7.4). The ghost pro- 
tein concentration was measured by the Lowry 
method [13] using crystalline bovine serum albumin 
as standard. The content of free sulphydryl groups in 
the membrane proteins was determined spectropho- 
tometrically at 412 nm using the Ellman method 
[14] involving 5,5 '-dithiobis-(2-nitrobenzoic ac d) 
(Sigma) as standard. Red cell membrane lipid peroxi- 
dation was assayed as in [15] using the thiobarbituric 
acid method for measuring malonyldialdehyde, a 
secondary breakdown product of polyunsaturated 
fatty acid peroxides. 
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Polyacrylamide gel electrophoresis was performed 
following the standard procedures [16,17] using 5% 
acrylamide gels. Gels were run at 5 mA/gel for 2 h, 
stained with Coomassie brilliant blue and scanned 
using a densitometer. 
Measurements of the fluidity of the lipid region of 
the membrane were performed using the apolar 
fluorescent polarisation probe, 1,6-diphenyl-1,3,5- 
hexatriene (Aldrich) on the Elscint MV-la Micro- 
viscosimeter (Elscint Ltd, Haifa) as outlined in [18]. 
Excitation was from polarised light (366 nm) and cor- 
rections were made for fight scattering by successively 
diluting the samples until the values for fluorescence 
polarisation reached a plateau. The observed polarisa. 
tion p, the average response under specific conditions 
[19], was transposed into fluorescence anisotropy r,
(r = 2p /3 -p  and then converted into the relative 
microviscosity parameter [(r o -  1)/r] -1, which is 
directly proportional to the rnicroviscosity, where r o 
is the limiting anisotropy for DPH, 0.362 [20]. 
Fluorescence measurements using the magnesium 
salt of 1-anilino-8-naphthalene sulphonate (ANS) 
(Eastman) were performed on a Perkin-Elmer Hitachi 
204 spectrofluorimeter as outlined in [21]. 
3. Results 
The G-6-PD deficient erythrocytes in the study 
contained an average l vel of glucose-6-phosphate 
dehydrogenase of ~25% of normal red cells (table 1). 
The lipid peroxidation level as measured by the 
production of malonyldialdehyde, formed during the 
breakdown of peroxidised fatty acid side chains of 
the phospholipids, was enhanced asshown in table 1. 
This was accompanied by the crosslinking of some of 
the sulphydryl groups of the membrane proteins to 
a small extent as shown by measurements of the 
concentration of free sulphydryl groups in the mem- 
brane (table 1). Polyacrylamide gel electrophoresis 
(fig.l) of these membranes showed that highM r
membrane polypeptide aggregates were formed 
Table 1 
The erythrocyte G-6-PD levels, membrane mieroviseosity, free sulphydryl 
contents, cholesterol:phospholipid ratio and lipid peroxidation levels of normal 
erythroeytes and those of patients with e common Mediterranean- and A-types 
of G-6-PD deficiency (standard deviations are shown) 
Control G-6-PD-deficient 
erythrocytes erythrocytes 
G-6-PD levels 133 + 12 32 + 26 
(mU/109 red cells) (5) (6) 
Peroxidation level 0.095 + 0.002 0.156 + 0.03 
(A s32/mg protein) (4) (6) 
Sulphydryl level 82 + 2 71 + 4 
(nmol/mg protein) (4) (6) 
Relative microviscosity 2.43 + 0.1 1.91 ± 0.2 
parameter at25"C (4) (6) 
[(ro_l)/r ] -a 
Cholesterol:phospholipid 0.89 + 0.07 0.66 + 0.05 
ratio (5) (5) 
ANS Binding constant 17.0 ~ 1 17.0 ± 1 
0zM) (3) (3) 
Number of ANS molecules 90.0 ± 5.0 220 + 20 
bound (nmol/g) (3) (3) 
The figures in brackets represent the number of samples 
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Fig.1. Polyacrylamide gel lectrophoresis in odium dodecyl sulphate of red cell membranes from patients with G-6-PDdeficiency 
of the common type (1); similar conditions to lane 1 except the samples were treated with dithiothreitol prior o electrophoresis 
(2); normal red ceil membranes (3). 
appearing at the top of the gel (lane 1) with a decrease 
in the intensity of the spectrin bands 1 and 2 and an 
obscuring of bands 4.1 and 4.2. The high M r aggre- 
gates disappeared when the samples were treated 
with dithiothreitol prior to electrophoresis (lane 2) 
and the protein patterns appeared more normal. This 
showed that the aggregates originated from cross- 
linked sulphydryl groups on the membrane proteins. 
Fluidity studies at 25°C on the apolar lipid region 
of the membrane, measured by incorporation of 
1,6-diphenyl-1,3,5-hexatriene, showed small increases 
in the average bulk lipid fluidity of the G-6-PD-defi- 
cient membranes a indicated by the decrease in the 
relative microviscosity parameter (table 1). The 
anionic amphipathic fluorescent probe ANS was 
used to seek information on changes in charge at the 
membrane surface. The fluorescence intensity, which 
is dependent on the polarity of the environment of 
the probe and the nvironmental constraints, wa  
decreased in the G-6-PD-deficient membranes. Titra- 
tions of varying concentrations of normal and G-6- 
PD-deficient membranes ata fixed concentration 
(10/aM) of ANS were performed and the double 
reciprocal plot extrapolated to estimate the limiting 
fluorescence enhancement when all the probe is 
bound to the membrane. Bound ANS in G-6-PD-defi- 
cient membranes is less fluorescent than in normal 
membranes, indicating different characteristics in the 
binding sites. There was, however, no change in the 
wavelength of maximum emission. To determine the 
number of binding sites for ANS and the binding con- 
stants, a Scatchard analysis was performed on the 
data as outlined in [22]. The results indicate that the 
binding of ANS to the membranes of G-6-PD-defi- 
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cient red cells is markedly increased in terms of the 
number of probe molecules bound (table 1) but the 
affinity of the membrane for the probe is unchanged 
at a dissociation constant of 17.0 -+ 1.0/aM. 
The cholesterol:phospholipid ratio in the G-6-PD- 
deficient membranes was decreased by 26%. The 
phospholipid content was not significantly altered 
but it was the cholesterol content that was lowered 
in this condition. Red cell ATP and DPG levels were 
normal suggesting the normal operation of the glyco- 
lytic pathway in this disorder. 
4. Discussion 
Normal red cells are capable of withstanding oxi- 
dative stress by increasing the activity of glucose-6- 
phosphate dehydrogenase (G-6-PD). The defective 
operation of the pentose phosphate pathway in red 
cells deficient in G-6-PD leads to the failure to main- 
tain glutathione in its reduced state; its role is to pro- 
tect the sulphydryl groups of the enzymes, haemo- 
globin and membrane proteins from oxidation. 
The resulting production of activated oxygen 
radicals and the increased oxidative stress manifests 
itself in an increase in the lipid breakdown product 
[23,24], malonyldialdehyde, resulting from the 
peroxidation of the lipid fatty acid chains with 4 or 
more conjugated double bonds, thereby increasing 
the ratio of saturated to unsaturated lipid fatty acyl 
chains. In the G-6-PD-deficient erythrocytes the 
increased bulk lipid fluidity is presumably a conse- 
quence of the decreased cholesterol:phospholipid ratio. 
This increase is consistent with a decreased lipid pack- 
Lug density [25]. It is not clear whether it s oxidation 
of cholesterol r decreased synthesis of cholesterol at 
the reticulocyte stage which is responsible for the 
changes in microviscosity in the G-6-PD-deficient 
mutants, ince NADPH, whose level is affected in this 
disorder, is required for cholesterol biosynthesis. Fur- 
thermore, since normally the unsaturated lipids are 
protected from free radical attack by the presence of 
cholesterol in biomembranes [26], this decreased cho- 
lesterol level may enhance their susceptibility o the 
reactivity of free radicals and therefore peroxidation. 
A similar elationship between lipid peroxidation and 
lipid fluidity has been shown in bovine red cell mem- 
branes during the onset of Heinz body anaemia which 
accompanies intensive brassica feeding [27]. Using 
electron spin resonance [28] an increase in the 
fluidity of the membrane in G-6-PD Helsinki cells 
was shown and a defect in the lipid region of the 
membranes suggested. 
Changes in the packing of ANS between the polar 
headgroups and changes in polar headgroup mobility 
express themselves through modifications in the 
accessibility of water to the ANS and the reduction 
of the quantum yield [29]. The decreased ANS fluo- 
rescence intensity and the increased number of ANS 
binding sites in the G-6-PD-deficient membranes 
suggests a less-ordered structure in the head-group 
region due to the decreased lipid packing density, 
possibly resulting from lipid peroxidation and lowered 
cholesterol levels. 
The drug-induced haemolysis which occurs in 
chronic G-6-PD-deficiency is a consequence of the 
oxidation of sulphydryl groups in the red ceil mem- 
brane;membrane ggregate formation ispathologically 
related to decreased red cell deformability [30,31 ]. 
Our studies suggest the presence ofhighM r membrane 
protein aggregates crosslinked via disulphide bridges 
in G-6-PD mutants of the non-haemolytic variety. 
Their formation ispresumably related in some way 
to the peroxidation level, as similar high M r polymers 
are formed in fresh erythrocytes treated chemically 
to induce peroxidation. (C. R. E., unpublished). 
This work implies that a further important con- 
tributing factor to the altered rheological properites 
of G-6-PD mutants i the restricted capacity of the 
cell to break down oxidising radicals, e.g., superoxide 
anions O~', which might participate in lipid peroxida- 
tion. Lipid peroxidation has also been implicated in 
the free radical reactions and membrane alterations 
associated with ageing cells and tissues [32,33] by 
initiating changes in their mechanical properties lead- 
ing to their entrapment in the fine circulation of the 
spleen [34,35]. 
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